Clinical Trial Update: A Study of RD06-04 in Patients With Active Autoimmune Diseases [EARLY_Phase 1]

View source ↗

Summary

A early Phase 1 study of RD06-04 in active autoimmune diseases has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis
• Idiopathic Inflammatory Myopathy
• Multiple Sclerosis
• Myasthenia Gravis
• Neuromyelitis Optica Spectrum Disorder
• Sjögren Syndrome
• Systemic Lupus Erythematosus
• Systemic Sclerosis

Drugs mentioned

• RD06-04

Snippet

Sponsor: Nanjing Bioheng Biotech Co., Ltd. | Conditions: SLE, Sclerosis | EARLY_Phase 1 | Status: WITHDRAWN